Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Molfino

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|January 22, 2023
Toward a Predict and Prevent Approach in Obstructive Airway DiseasesSimon Couillard, Nayia Petousi, Kate S Smigiel, et al.
Inflammation & Allergy Drug Targets|March 25, 2011
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthmaChad K Oh, Donald Raible, Gregory P Geba, et al.
Chest|August 1, 1996
Tracheobronchial constriction in asthmatics induced by isocapnic hyperventilation with dry cold airG Julià-Serdà, N A Molfino, N Califaretti, et al.
Muscle & Nerve|July 13, 2002
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravisLucas Gustavo De Feo, Juan Schottlender, Néstor A Martelli, et al.
The New England Journal of Medicine|January 31, 1991
Respiratory arrest in near-fatal asthmaN A Molfino, L J Nannini, A N Martelli, et al.
Chest|March 1, 1992
The fatality-prone asthmatic patient. Follow-up study after near-fatal attacksN A Molfino, L J Nannini, A S Rebuck, et al.
Medicina|January 1, 1994
Trends in pharmacotherapy for chronic airflow limitation in Argentina: 1983-1990N A Molfino, L J Nannini, K R Chapman, et al.
BMC Pulmonary Medicine|January 13, 2010
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthmaDave Singh, Binita Kane, Nestor A Molfino, et al.
Advances in Therapy|November 18, 2024
Predicting Asthma Exacerbations Using Machine Learning ModelsGianluca Turcatel, Yi Xiao, Scott Caveney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 19, 2011
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptorN A Molfino, D Gossage, R Kolbeck, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology. in Practice|January 22, 2023
Toward a Predict and Prevent Approach in Obstructive Airway DiseasesSimon Couillard, Nayia Petousi, Kate S Smigiel, et al.
Inflammation & Allergy Drug Targets|March 25, 2011
Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthmaChad K Oh, Donald Raible, Gregory P Geba, et al.
Chest|August 1, 1996
Tracheobronchial constriction in asthmatics induced by isocapnic hyperventilation with dry cold airG Julià-Serdà, N A Molfino, N Califaretti, et al.
Muscle & Nerve|July 13, 2002
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravisLucas Gustavo De Feo, Juan Schottlender, Néstor A Martelli, et al.
The New England Journal of Medicine|January 31, 1991
Respiratory arrest in near-fatal asthmaN A Molfino, L J Nannini, A N Martelli, et al.
Chest|March 1, 1992
The fatality-prone asthmatic patient. Follow-up study after near-fatal attacksN A Molfino, L J Nannini, A S Rebuck, et al.
Medicina|January 1, 1994
Trends in pharmacotherapy for chronic airflow limitation in Argentina: 1983-1990N A Molfino, L J Nannini, K R Chapman, et al.
BMC Pulmonary Medicine|January 13, 2010
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthmaDave Singh, Binita Kane, Nestor A Molfino, et al.
Advances in Therapy|November 18, 2024
Predicting Asthma Exacerbations Using Machine Learning ModelsGianluca Turcatel, Yi Xiao, Scott Caveney, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|November 19, 2011
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptorN A Molfino, D Gossage, R Kolbeck, et al.
Pageof 9